Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascletis Announces Strategic Decisions on FXR agonist ASC42 2024-04-03 17:10
Nagase Viita Receives Highest "Platinum" Rating for Sustainability from EcoVadis 2024-04-03 14:00
I-Mab Announces Closing of the Divestiture of Business Operations in China 2024-04-03 04:01
GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 2024-04-02 23:00
HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device 2024-04-02 21:00
China Medical University Hospital, Collaborated with Microsoft Taiwan, Launched GenAI: gHi System 2024-04-02 20:30
Innovating "Treadmill Exercise Test AI-Assisted Interpretation System," CMUH(Taiwan) Timely Saves More Patients with Severe Myocardial Infarction 2024-04-02 20:30
China Medical University Hospital Develops "AISIA" to Diagnose Acute Ischemic Stroke in 90 Seconds to Assist Doctors in Making Medical Decisions 2024-04-02 20:30
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH 2024-04-02 20:00
Gushengtang Releases 2023 Annual Results: Sustained Growth with Robust Profit Increase 2024-04-02 16:49
23WELL, THE health supplement brand on the watch 2024-04-02 09:07
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification 2024-04-01 21:00
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO 2024-04-01 14:30
OFFICIAL LAUNCH OF THE NATIONAL UNIVERSITY SPINE INSTITUTE (NUSI): LEADING SPINE CARE INTO THE FUTURE 2024-03-30 11:00
Baird Medical Granted New Class III Certificate by China's NMPA for Ceramic Thyroid Ablation Needle 2024-03-29 21:37
LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) 2024-03-29 21:00
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis 2024-03-29 20:40
Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 2024-03-29 20:00
IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma 2024-03-29 17:20
Jacobio Pharma Announces 2023 Annual Results 2024-03-29 08:50
1 41 42 43 44 45 800